UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies
The University of Chicago Medicine Comer Children’s Hospital will be among the first in the country to offer gene therapy for sickle cell disease in patients 12 years and older, after federal regulators approved two new treatments on December 8, 2023.
Thousands of patients with sickle cell disease experience vaso-occlusive crises (VOCs), which are often painful and frequently require hospitalization. The two new potentially curative treatments show promise for eliminating VOCs and offer an alternative to bone marrow transplants, which can be arduous and carry risk of rejection even if a matching donor is found.
People ...












